Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with Polycystic Ovary Syndrome have a higher chance of getting depressed.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

Women with acne often have higher levels of male hormones and are more likely to be overweight, both of which can make acne worse.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Poor nutrition, higher BMI, and stress may worsen seborrheic dermatitis.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.